Eosinophils Derived from Acute Promyelocytic Leukemia Cells after Arsenic Trioxide Treatment

  • Kazuhito Yamamoto
  • Nobuhiko Emi
  • Tomohiro Kajiguchi
  • Shunji Yamamori
  • Yoshitaka Ono
  • Tomoki Naoe
Letter to the editor

References

  1. 1.
    Melnick A, Licht JD. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93:3167–3215.PubMedGoogle Scholar
  2. 2.
    Chen GQ, Shi XG, Tang W, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL), I: As2O3 exerts dose-dependent dual effects on APL cells. Blood. 1997;89:3345–3353.PubMedGoogle Scholar
  3. 3.
    Kitamura K, Minami Y, Yamamoto K, et al. Involvement of CD95- independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia. 2000;14:1743–1750.PubMedCrossRefGoogle Scholar
  4. 4.
    Camacho LH, Soignet SL, Chanel S, et al. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol. 2000;18:2620–2625.PubMedGoogle Scholar
  5. 5.
    Ghosh K, Varma N, Dash S. Dysplastic eosinophils in three patients with acute promyelocytic leukaemia. Leuk Res. 1988;12:963–967.PubMedCrossRefGoogle Scholar
  6. 6.
    Kishi K, Toba K, Azegami T, et al. Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukemia cell line with t(15;17). Exp Hematol. 1998;26:135–142.PubMedGoogle Scholar
  7. 7.
    Metcalf D. Clonal analysis of the response of HL60 human myeloid leukemia cells to biological regulators. Leuk Res. 1983;7:117–132.PubMedCrossRefGoogle Scholar
  8. 8.
    van Dijk TB, Caldenhoven E, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP. The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene. Blood. 1998;91:2126–2132.PubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2007

Authors and Affiliations

  • Kazuhito Yamamoto
    • 1
    • 2
  • Nobuhiko Emi
    • 1
    • 3
  • Tomohiro Kajiguchi
    • 1
  • Shunji Yamamori
    • 4
  • Yoshitaka Ono
    • 5
  • Tomoki Naoe
    • 1
  1. 1.Department of Hematology and OncologyNagoya University Graduate School of MedicineAichiJapan
  2. 2.Department of Hematology and Cell TherapyAichi Cancer Center HospitalAichiJapan
  3. 3.Department of Hematology and ChemotherapyFujita Health University HospitalAichiJapan
  4. 4.Mitsubishi Kagaku Bio-Clinical Laboratory, IncTokyoJapan
  5. 5.Department of Internal MedicineAnjo Kosei HospitalAichiJapan

Personalised recommendations